The Environmental Protection Agency has awarded $1.9 million to a researcher at the University of Arkansas to study the effects of adding biochar to poultry litter and how it could improve water ...

Eli Lilly LLY announced positive top-line results from a late-stage study evaluating its experimental once-weekly weight-loss drug, retatrutide, in adults with type II diabetes (T2D) This study, ...

Genentech is halting development of an antibody for two rare genetic diseases after the candidate failed to boost muscle growth, raising questions about whether the molecule can preserve muscle in two ...

Gilead HPI licensing adds $35M now + $330M milestones; Phase 2 starts by 2026; strong cash runway. Click for this ASMB update ...

Explore Eli Lilly and Company stock: obesity drug tirzepatide sales +115%, new retatrutide diabetes data, and Kisunla ...

Nektar Therapeutics (Nasdaq: NKTR) announced today that data from the ongoing Phase 2b studies of rezpegaldesleukin in atopic ...

Among children, adolescents and adults with peanut allergy, a once-daily peanut sublingual immunotherapy tablet was well tolerated up to the highest dose in an up-dosing regimen, according to phase ...

Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management of HAE ZUG, Switzerland, March 20, 2026 (GLOBE NEWSWIRE) ...

After a strong start to the year, the value of biotech financings has tailed off a little, but March has seen a clutch of $50 ...

Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any time and a durable 76% CR rate at 12 months, with favorabl ...

Proposed acquisition supports the Novartis oncology strategy in hormone receptor positive, human epidermal growth factor receptor two-negative (HR+/HER2-) breast cancer ; The lead ...